Immunity to SARS-CoV-2 Lasts at Least Six Months, Data Show
Immunity to SARS-CoV-2 Lasts at Least Six Months, Data Show
Half a year after infection, people who had recovered from COVID-19 had robust antibodies, along with traces of the virus in their gut, which may drive long-lasting immunity.
Immunity to SARS-CoV-2 Lasts at Least Six Months, Data Show
Immunity to SARS-CoV-2 Lasts at Least Six Months, Data Show

Half a year after infection, people who had recovered from COVID-19 had robust antibodies, along with traces of the virus in their gut, which may drive long-lasting immunity.

Half a year after infection, people who had recovered from COVID-19 had robust antibodies, along with traces of the virus in their gut, which may drive long-lasting immunity.

B cells
T Cells: A New Hope for Lasting Protection against SARS-CoV-2
T Cells: A New Hope for Lasting Protection against SARS-CoV-2
The Scientist Creative Services Team | Dec 15, 2020
Alessandro Sette and Shane Crotty discuss the T cell response to SARS-CoV-2 and the implications for vaccine design and robust immune memory.
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Anthony King | Nov 11, 2020
Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 
Cracking Down on Cancer: A Profile of Owen Witte
Cracking Down on Cancer: A Profile of Owen Witte
Diana Kwon | Apr 1, 2020
Through his studies on cancer-causing viruses, the University of California, Los Angeles, professor has helped develop lifesaving treatments.
Gene Therapy Effective for Severe Combined Immunodeficiency
Gene Therapy Effective for Severe Combined Immunodeficiency
Shawna Williams | Apr 17, 2019
Researchers report they’ve found a way to restore immune function in infants with one form of “bubble boy disease.”
Culprit for Antibody Blockade Identified
Culprit for Antibody Blockade Identified
Amanda B. Keener | Oct 21, 2016
Type I interferon organizes several immune mechanisms to suppress B cell responses to a chronic viral infection.
Enhancing Vaccine Development
Enhancing Vaccine Development
Wudan Yan | Jun 1, 2016
Using proteomics methods to inform antigen selection
When the Flu Vax Fails
When the Flu Vax Fails
Jef Akst | Dec 16, 2015
The status of a person’s immune system can predict when a seasonal flu vaccination will not provide sufficient protection, according to a study. 
B Cells Can Drive Inflammation in MS
B Cells Can Drive Inflammation in MS
Anna Azvolinsky | Oct 21, 2015
Researchers identify a subset of proinflammatory cytokine-producing B cells that may spark multiple sclerosis-related inflammation.  
Studying Ebola Survivors
Studying Ebola Survivors
Amanda B. Keener | Apr 6, 2015
A scientist jumps at the chance to study the blood of four Ebola survivors to better understand how the immune system responds to the deadly virus.